Replies to post #160276 on Cytodyn Inc (CYDY)

[stockorus]

So there is no restriction in number of doses for the LH trial? FDA must really trust the safety of LL to have allowed 6 doses in a trial for a new indication. Logically then they should approve our request for 4 doses for critical patients.

Not as clear how CCR5 is involved in LH cases. They are not in the cytokine storm of critical patients, yet the same issue must be happening in some prolonged low-level sense that LL is hopefully helping resolve.